KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Mark R Warner (Senate) disclosed 1 transaction

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

2017-11-06 · sellHalozyme Therapeutics, Inc. — $500,001 - $1,000,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

idsenate-d94f6136-fd12-4105-910f-6f52c771faee-1
ownerSelf
partyDemocrat
stateVA
officeWarner, Mark R (Senator)
ptr idd94f6136-fd12-4105-910f-6f52c771faee
tickerHALO
chambersenate
commentUnderlying asset of MRW Biotech Investors, LLC. Previously held in New River Management V.
amount max1000000
amount min500001
asset nameHalozyme Therapeutics, Inc.
asset typeStock
report urlhttps://efdsearch.senate.gov/search/view/ptr/d94f6136-fd12-4105-910f-6f52c771faee/
bioguide idW000805
data sourceSENATE_EFD_PTR
member lastWarner
member nameMark R Warner
amount range$500,001 - $1,000,000
member firstMark R
state district—
disclosure date2017-12-08
amendment statusoriginal
transaction date2017-11-06
transaction typesell
reporting lag days23
transaction natureOPEN_MARKET

Original filing document